Literature DB >> 19245128

Idiopathic thrombocytopenic purpura.

Geetha Palaniappan1, William Jennings.   

Abstract

Immune Thrombocytopenic Purpura (ITP) is an immune mediated disorder characterized by low platelet counts from peripheral destruction. While in children the disease is self-limiting, in adults it runs an insidious and chronic course. The goal of treatment should be the maintenance of a platelet count sufficient to prevent bleeding. Most of the earlier treatment regimens such as corticosteroids, intravenous immunoglobulin and splenectomy were directed towards reducing peripheral destruction. However, newer agents to stimulate thrombopoiesis are under investigation and have demonstrated early encouraging results.

Entities:  

Mesh:

Year:  2009        PMID: 19245128

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  2 in total

1.  Immune thrombocytopenic purpura might be an early hematologic manifestation of undiagnosed human immunodeficiency virus infection.

Authors:  Shih-Wei Lai; Hsien-Feng Lin; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Intern Emerg Med       Date:  2016-08-25       Impact factor: 3.397

2.  Study on the Role of Calreticulin Within Platelet from Adult Patients with Chronic Immune Thrombocytopenic Purpura.

Authors:  Kam Chau Yung; Ze Wen Zhang; Wen Jun Yu; Jin Feng Qiu; Cheng Wei Xu; Chun Ling He; Xian Ru Xu; Jun Yin
Journal:  Indian J Hematol Blood Transfus       Date:  2018-04-02       Impact factor: 0.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.